There are many patients with chronic viral hepatitis B in China. Among them, hepatitis B major triple-positive patients have serious liver function damage and the virus is highly contagious, which seriously endangers people’s life and health. Today we will talk about how to treat patients with hepatitis B major triple-positive. The early stage of chronic viral hepatitis B patients often only have liver function insufficiency performance, this stage of liver cell damage is light, hepatitis B virus is less infectious. If you can give timely liver protection and antiviral treatment, you can often achieve better treatment results. However, because patients do not have obvious clinical table many patients tend to ignore the disease, leading to further aggravation. Once the disease has developed into hepatitis B major third-positive, antiviral treatment is often required. Commonly used antiviral drugs include entecavir, lamivudine, adefovir, etc. Anti-viral drugs need to be taken continuously for at least 3 to 5 years, and cannot be stopped or reduced casually to avoid repeated hepatitis B virus levels. If hepatitis B patients have elevated liver transaminases and bilirubin, they need to be given supportive treatment such as liver protection, cholestasis and anti-yellowing. Commonly used hepatoprotective drugs include glutathione, polyenylphosphatidylcholine, magnesium isoglycyrrhizate, semtex, regan and so on. In addition, diet and adequate rest are also essential for the recovery of liver function. Hepatitis B patients should try to eat low fat, high fiber and high vitamin foods, and avoid spicy, stimulating, cold and greasy foods. Quit smoking and drinking and don’t stay up late. Protect your liver cells from further damage as much as possible.